Anna Brandt
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Pluripotent Stem Cells Research 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 2
- Co-authors
- Mascha Binder (7 shared papers)Thomas G.P. Bumm (1 shared paper)Ralf C. Bargou (1 shared paper)Friederike Braig (1 shared paper)Sebastian Böttcher (1 shared paper)Peter Nollau (1 shared paper)Mariele Goebeler (1 shared paper)Hans‐Peter Tony (1 shared paper)
- Journals
- Chemico-Biological Interactions (2 papers)Haematologica (1 paper)Blood Cancer Journal (1 paper)npj Precision Oncology (1 paper)Blood (1 paper)
- Partner nations
- BrazilGermanySwitzerland
In The Last Decade
Anna Brandt
15 papers receiving 477 citations
Peers
Comparison fields: 5 of 75
- Oncology 233
- Hematology 95
- Genetics 46
- Immunology 94
- Cancer Research 51
Countries citing papers authored by Anna Brandt
This map shows the geographic impact of Anna Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Brandt more than expected).
Fields of papers citing papers by Anna Brandt
This network shows the impact of papers produced by Anna Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Brandt. The network helps show where Anna Brandt may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Brandt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 197 | |
| 2 | 2017 | 82 | |
| 3 | 2016 | 42 | |
| 4 | 2016 | 37 | |
| 5 | 2014 | 25 | |
| 6 | 2017 | 24 | |
| 7 | 2018 | 19 | |
| 8 | 2016 | 12 | |
| 9 | 2012 | 11 | |
| 10 | 2014 | 8 | |
| 11 | 2024 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2016 | 6 | |
| 14 | 2016 | 3 | |
| 15 | 2025 | 1 | |
| 16 | 2001 | 0 |
About Anna Brandt
Anna Brandt is a scholar working on Molecular Biology, Oncology, Physiology, Cancer Research and Pharmacology, having authored 16 papers that have together received 480 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Head and Neck Cancer Studies (1 paper), Pluripotent Stem Cells Research (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Oncology (233 citations), Hematology (95 citations), Genetics (46 citations), Immunology (94 citations) and Cancer Research (51 citations). Anna Brandt has collaborated with scholars based in Brazil, Germany and Switzerland. Frequent co-authors include Mascha Binder, Thomas G.P. Bumm, Ralf C. Bargou, Friederike Braig, Sebastian Böttcher, Peter Nollau, Mariele Goebeler, Hans‐Peter Tony, Sílvia Maria Suter Correia Cadena and Benjamin Thiele. Their work appears in journals such as Chemico-Biological Interactions, Haematologica, Blood Cancer Journal, npj Precision Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.